Search results
Merck Stock Jumps After Dow Jones Stalwart Rides Its Cancer 'Star' To Another Quarterly Beat
Investor's Business Daily· 6 days agoMerck stock popped Thursday after the Dow Jones stalwart topped Wall Street's first-quarter views on...
Treatment Options for HER2-Negative Breast Cancer
Healthline· 7 days agoMost breast cancers are HER2-negative. There are many treatment options for this type of breast cancer. Your treatment
Merck raises 2024 profit forecast on strong sales of cancer drug Keytruda By Reuters
Investing.com· 6 days agoKeytruda, the world's top selling drug in 2023, has been Merck's key revenue driver over the past...
U.K. Tests World-First Personalized Skin Cancer Vaccine
Forbes· 5 days agoBritish patients are trying a first-of-its-kind customized vaccine for skin cancer as part of a...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 7 days agoOverall, 27.3% responded to the treatment. A total of 63.6% of patients had their disease under...
British patients test world’s first personalised mRNA jab for melanoma
Press Association News via AOL· 5 days agoThe therapy combination is also being trialled in lung, bladder and kidney cancer. One of the first...
Merck shares target raised on strong Q1 performance By Investing.com
Investing.com· 6 days agoOn Thursday, Truist Securities adjusted the stock price target for Merck (NYSE:MRK), a global...
British man tests first personalised melanoma vaccine
BBC via Yahoo News· 5 days agoHospitals (UCLH) doctors are giving it alongside another drug, pembrolizumab or Keytruda, that also...
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
CNBC· 6 days agoMerck on Thursday reported first-quarter revenue and adjusted earnings that topped expectations as...
Merck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoMerck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript April 25, 2024 Merck & Co., Inc. beats...